Clinical Trial Update: BRCA Founder OutReach (BFOR) Study

View source ↗

Summary

The BRCA Founder OutReach (BFOR) Study sponsored by Memorial Sloan Kettering Cancer Center is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hereditary Breast and Ovarian Cancer Syndrome
• Ovarian Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: BRCA1 Mutation, BRCA2 Mutation | Status: ACTIVE_NOT_RECRUITING